Table of Contents Author Guidelines Submit a Manuscript
Prostate Cancer
Volume 2011, Article ID 236357, 5 pages
http://dx.doi.org/10.1155/2011/236357
Clinical Study

First Danish Single-Institution Experience with Radical Prostatectomy: Biochemical Outcome in 1200 Consecutive Patients

Department of Urology, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, Afsnit 2112, 2100 Copenhagen Ø, Denmark

Received 30 June 2010; Revised 19 September 2010; Accepted 11 November 2010

Academic Editor: Manfred P. Wirth

Copyright © 2011 M. Andreas Røder et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Brasso, P. Ingeholm, and P. Iversen, “Radical prostatectomy: the first consecutive patients operated on at Rigshospitalet,” Ugeskrift for Laeger, vol. 163, no. 41, pp. 5669–5673, 2001. View at Google Scholar · View at Scopus
  2. K. Brasso, “Prostate cancer—incidence and risk factors,” Ugeskrift for Laeger, vol. 169, no. 20, pp. 1883–1886, 2007. View at Google Scholar · View at Scopus
  3. K. Brasso, I. J. Ingimarsdottir, L. Thomassen, S. Friis, and P. Iversen, “Prostate cancer in Denmark 1943–2002,” Ugeskrift for Laeger, vol. 169, no. 2, pp. 129–132, 2007. View at Google Scholar · View at Scopus
  4. P. C. Walsh, A. B. Retik, E. D. Vaughan, and A. J. Wein, Cambell's Urology, Saunders, 8th edition, 2002.
  5. L. Holmberg, A. Bill-Axelson, F. Helgesen et al., “A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer,” New England Journal of Medicine, vol. 347, no. 11, pp. 781–789, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Zinoke, J. E. Oesterling, M. L. Blute, E. J. Bergstralh, R. P. Myers, and D. M. Barrett, “Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer,” Journal of Urology, vol. 152, no. 5, pp. 1850–1857, 1994. View at Google Scholar
  7. M. L. Blute, E. J. Bergstralh, A. Iocca, B. Scherer, and H. Zincke, “Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy,” Journal of Urology, vol. 165, no. 1, pp. 119–125, 2001. View at Google Scholar · View at Scopus
  8. G. S. Gerber, R. A. Thisted, P. T. Scardino et al., “Results of radical prostatectomy in men with clinically localized prostate cancer: multi-institutional pooled analysis,” Journal of the American Medical Association, vol. 276, no. 8, pp. 615–619, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Hernandez, M. E. Nielsen, M. Han, and A. W. Partin, “Contemporary evaluation of the D'Amico risk classification of prostate cancer,” Urology, vol. 70, no. 5, pp. 931–935, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Boorjian, R. J. Karnes, L. J. Rangel, E. J. Bergstralh, and M. L. Blute, “Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy,” Journal of Urology, vol. 179, no. 4, pp. 1354–1361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. G. W. Hull, F. Rabbani, F. Abbas, T. M. Wheeler, M. W. Kattan, and P. T. Scardino, “Cancer control with radical prostatectomy alone in 1,000 consecutive patients,” Journal of Urology, vol. 167, no. 2, pp. 528–534, 2002. View at Google Scholar · View at Scopus
  12. A. V. D'Amico, R. Whittington, S. Bruce Malkowicz et al., “Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer,” Journal of the American Medical Association, vol. 280, no. 11, pp. 969–974, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. M. W. Kattan, J. A. Eastham, A. M. F. Stapleton, T. M. Wheeler, and P. T. Scardino, “A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer,” Journal of the National Cancer Institute, vol. 90, no. 10, pp. 766–771, 1998. View at Google Scholar · View at Scopus
  14. C. C. Schulman, “Neoadjuvant androgen blockade prior to prostatectomy: a retrospective study and critical review,” Prostate, vol. 24, no. 5, pp. 9–14, 1994. View at Google Scholar · View at Scopus
  15. H. Van Poppel, D. De Ridder, A. A. Elgamal et al., “Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial,” Journal of Urology, vol. 154, no. 2, pp. 429–434, 1995. View at Publisher · View at Google Scholar
  16. G. Aus, P. A. Abrahamsson, G. Ahlgren et al., “Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial,” BJU International, vol. 90, no. 6, pp. 561–566, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. O. A. Armas, A. G. Aprikian, J. Melamed et al., “Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma,” American Journal of Surgical Pathology, vol. 18, no. 10, pp. 979–991, 1994. View at Google Scholar · View at Scopus
  18. A. Bill-Axelson, L. Holmberg, M. Ruutu et al., “Radical prostatectomy versus watchful waiting in early prostate cancer,” New England Journal of Medicine, vol. 352, no. 19, pp. 1977–1984, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Røder, L. Gruschy, K. Brasso, and P. Iversen, “Early complications following open radical prostatectomy,” Ugeskrift for Laeger, vol. 171, no. 18, pp. 1492–1496, 2009. View at Google Scholar · View at Scopus
  20. J. A. Mitchell, M. R. Cooperberg, E. P. Elkin et al., “Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE,” Journal of Urology, vol. 173, no. 4, pp. 1126–1131, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. A. V. D'Amico, R. Whittington, S. B. Malkowicz et al., “Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era,” Journal of Urology, vol. 166, no. 6, pp. 2185–2188, 2001. View at Google Scholar · View at Scopus
  22. A. V. D'Amico, R. Whittington, S. B. Malkowicz et al., “Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era,” Cancer, vol. 95, no. 2, pp. 281–286, 2002. View at Publisher · View at Google Scholar · View at Scopus